Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

NCT06263998 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Xerophthalmia

Interventions

DRUG: NCP112
DRUG: NCP112 Placebo

Sponsor

Huons Co., Ltd.